Ready 8-Ks
50
Latest filing
July 27, 2026, 4:17 PM ET
Top materiality
0.80
Event mix
earnings ×18 · other_material ×10 · dividend ×9
Sentiment
20 pos · 2 neg · 28 neu
Latest earnings
reported 2026-Q3
-
Southern Missouri Bancorp Q4 EPS $1.83, up 31.7% YoY; dividend raised 8% to $0.27
Diluted EPS $1.83 for Q4 FY2026, up 31.7% from $1.39 in Q4 FY2025 and up 14.4% from Q3 FY2026.
-
Southern Missouri Bancorp Q4 net income $20.3M (+28.5% YoY); EPS $1.83; dividend raised to $0.27
Q4 diluted EPS $1.83 vs $1.39 YoY; full-year EPS $6.43 vs $5.18 YoY.
-
Southern Missouri Bancorp reports Q3 FY2026 EPS $1.60, up 15.1% YoY; declares $0.25 dividend
Net income $17.8M, diluted EPS $1.60 vs $1.39 a year ago (up 15.1%).
-
Southern Missouri Bancorp reports Q2 EPS $1.62, up 24.6% YoY; authorizes 5% buyback
EPS (diluted) $1.62 for Q2 FY2026, up 24.6% YoY from $1.30 and up 17.4% sequentially.
-
Southern Missouri Bancorp Q2 FY2026 net income $18.2M, EPS $1.62, dividend and new buyback authorized
Net income $18.2M, up 23.9% YoY; diluted EPS $1.62 vs $1.30 YoY.
-
SMBC Q1 FY2026 diluted EPS $1.38, up 25.5% YoY; tangible book value $43.35
Diluted EPS $1.38 for Q1 FY2026, up 25.5% YoY from $1.10. Driven by 8% earning asset growth and NIM expansion.
-
Southern Missouri Bancorp Q1 net income $15.7M, EPS $1.38, up 25.6% YoY; NIM expands to 3.57%
Net income $15.7M (+25.6% YoY); diluted EPS $1.38 vs $1.10; NIM 3.57% (+23 bps).
-
Southern Missouri Bancorp posts FY2025 EPS $5.18, up 17% YoY; TBV $41.87
Diluted EPS $5.18 for FY2025, up $0.76 or 17.2% from $4.42 in FY2024.
-
SMBC Q4 net income $15.8M (+16.7%); EPS $1.39; NPLs rise to $23M; dividend +8.7%
Q4 net income $15.8M, diluted EPS $1.39 (vs $1.19 YoY), revenue up on NIM expansion to 3.46%.
-
SMBC Q3 FY2025 EPS $1.39, up 40.4% YoY; NPLs rise to $22M from $6.7M
Net income $15.7M, EPS $1.39 diluted, up 40.4% YoY and 6.9% linked quarter.
-
Southern Missouri Bancorp Q2 net income $14.7M (+20.2%), EPS $1.30, NIM 3.36%
Net income $14.7M, up $2.5M (+20.2%) YoY; diluted EPS $1.30 vs $1.07 prior year.
-
Southern Missouri Bancorp presents FY2024 results; diluted EPS $4.04, dividend raised 9.5% to $0.23
FY2024 diluted EPS $4.04, core diluted EPS $4.42; Q4 diluted EPS $1.19, down 13.1% YoY but up 20.2% linked quarter.
-
Southern Missouri Bancorp Q4 net income down 13% to $13.5M; raises dividend 9.5% to $0.23
Diluted EPS $1.19, down 13.1% YoY from $1.37; full-year FY2024 EPS $4.42, up from $3.85.
-
Southern Missouri Bancorp Q3 net income $11.3M, EPS $0.99, declares $0.21 dividend
Preliminary Q3 net income $11.3M (EPS $0.99) vs $2.4M ($0.22) a year ago, up 369% and 350% respectively.
-
SMBC reports Q2 FY2024 net income $12.2M (+4.5%); diluted EPS $1.07 (-15.1% YoY)
Net income $12.2M vs $11.7M in Q2 FY2023; diluted EPS $1.07 vs $1.26.
-
SMBC Q1 net income $13.2M (+36.9%); diluted EPS $1.16, up 11.5% YoY
Net income $13.2M ($1.16 diluted EPS), up from $9.7M ($1.04) in prior-year quarter.
-
SMBC reports Q4 net income up 18.9% to $15.6M; diluted EPS $1.37 vs $1.41 YoY
Diluted EPS of $1.37 for Q4 FY2023, down $0.04 YoY; full-year EPS $3.85 vs $5.21.
-
Southern Missouri Bancorp CFO resigns; quarterly dividend declared
CFO Lora Daves resigns effective Aug 4, 2023 to pursue other interests.
-
Southern Missouri Bancorp Q3 net income falls 74% to $2.4M on $10.1M credit loss provision from Citizens merger
Diluted EPS of $0.22, down 78.6% from $1.03 in prior-year quarter; after-tax merger charges reduced EPS by $0.73.
-
Southern Missouri Bancorp presents at Piper Sandler conference; pro forma assets $4.4B after Citizens merger
Assets $3.5B, loans $3.0B, deposits $3.0B, equity $337M as of Dec 31, 2022.
-
Southern Missouri Bancorp Q2 FY2023 EPS $1.26, down 6.7% YoY; dividend $0.21
Preliminary net income $11.7M ($1.26 diluted EPS), down 2.7% YoY but up 21.2% from linked quarter.
-
Southern Missouri Bancorp completes $131.4M acquisition of Citizens Bancshares Co.
Consideration: $131.4M total (74% stock, 26% cash); each Citizens share exchanged for 1.1755 SMBC shares or $54.93 cash.
-
SMBC shareholders approve stock issuance for Citizens merger; regulatory approvals obtained
Shareholders voted 7,206,429 for, 4,841 against, 189,999 abstain on share issuance for Citizens merger.